ETHOPHARMACOLOGICAL STUDIES DIFFERENTIATE THE EFFECTS OF VARIOUS SEROTONERGIC COMPOUNDS ON AGGRESSION IN RATS

被引:20
作者
MOS, J
OLIVIER, B
TULP, MTM
机构
[1] Department of CNS Pharmacology, Weesp
关键词
RAT; MALE; FEMALE; MATERNAL AGGRESSION; RESIDENT-INTRUDER AGGRESSION; SEROTONIN; BUSPIRONE; IPSAPIRONE; 8-OH-DPAT; RU-24969; ELTOPRAZINE; TFMPP; FLUVOXAMINE; DOI; QUIPAZINE; ETHOPHARMACOLOGY; BEHAVIORAL SPECIFICITY; 5-HT RECEPTOR (SUB)TYPES;
D O I
10.1002/ddr.430260311
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of experiments was performed to investigate the effects on aggression of various drugs affecting serotonergic transmission in rats. Using ethologically derived behavioural categories, the behaviour of treated animals was described. Drug effects were observed in two aggression models: resident-intruder aggression (RI) in male rats, and maternal aggression in lactating females during the postpartum period (MA). The 5-HT1A agonists, buspirone, ipsapirone, and 8-OH-DPAT, decreased aggression in RI and MA but simultaneously led to a marked decrease in social interest and activity, indicative of a nonspecific anti-aggressive profile. Nonselective 5-HT agonists, such as RU 24969, eltoprazine (DU 28853), and TFMPP, reduced aggression quite specifically and did not decrease social interest or exploration, but sometimes even increased these behaviours. In RI and MA, the behavioural effects of these drugs were roughly similar. By contrast, MA was more sensitive to the treatment with the 5-HT reuptake blocker fluvoxamine, which blocked RI aggression only nonspecifically at the highest dose. DOI, a 5-HT2 and 5-HT1C agonist, decreased aggressive behaviour and increased inactivity, without affecting social interest and exploration in RI as well as MA. This was, however, accompanied by "wet dog shaking," characteristic of 5-HT2-receptor stimulation. The nonspecific 5-HT agonist (and 5-HT3 antagonist) quipazine also induced "wet dog shaking" at doses that suppressed aggression, social interest and exploration but increased inactive behaviours (sitting and lying). The discussion attempts to delineate a role for 5-HT receptor subtype involvement in the modulation of aggression, with the restrictions we clearly face with regard to the lack of specific serotonergic agonists and antagonists for certain receptor subtypes. By and large, male and female rats react similarly to treatment with serotonergic drugs stressing the consistent role of 5-HT in different forms of aggression.
引用
收藏
页码:343 / 360
页数:18
相关论文
共 71 条
[1]  
[Anonymous], 1956, NONPARAMETRIC STAT B
[2]   PROPOSALS FOR THE CLASSIFICATION AND NOMENCLATURE OF FUNCTIONAL RECEPTORS FOR 5-HYDROXYTRYPTAMINE [J].
BRADLEY, PB ;
ENGEL, G ;
FENIUK, W ;
FOZARD, JR ;
HUMPHREY, PPA ;
MIDDLEMISS, DN ;
MYLECHARANE, EJ ;
RICHARDSON, BP ;
SAXENA, PR .
NEUROPHARMACOLOGY, 1986, 25 (06) :563-576
[3]   PHARMACOLOGICAL CHARACTERIZATION OF BENZODIAZEPINE RECEPTORS IN BRAIN [J].
BRAESTRUP, C ;
SQUIRES, RF .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1978, 48 (03) :263-270
[4]  
BURT DR, 1976, MOL PHARMACOL, V12, P800
[5]   H-3-SPIROPERIDOL LABELS DOPAMINE RECEPTORS IN PITUITARY AND BRAIN [J].
CREESE, I ;
SCHNEIDER, R ;
SNYDER, SH .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1977, 46 (04) :377-381
[6]   H-3-SPIROPERIDOL LABELS SEROTONIN RECEPTORS IN RAT CEREBRAL-CORTEX AND HIPPOCAMPUS [J].
CREESE, I ;
SNYDER, SH .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1978, 49 (02) :201-202
[7]   COMPARISON OF REGIONAL SEROTONIN LEVELS AND TURNOVER IN BRAIN OF NATURALLY HIGH AND LOW AGGRESSIVE RATS [J].
DARUNA, JH ;
KENT, EW .
BRAIN RESEARCH, 1976, 101 (03) :489-501
[8]  
DOODS H, 1987, THESIS U AMSTERDAM N
[9]   THE BINDING OF [H-3]-LABELED NITRENDIPINE TO RECEPTORS FOR CALCIUM-CHANNEL ANTAGONISTS IN THE HEART, CEREBRAL-CORTEX, AND ILEUM OF RATS [J].
EHLERT, FJ ;
ROESKE, WR ;
ITOGA, E ;
YAMAMURA, HI .
LIFE SCIENCES, 1982, 30 (25) :2191-2202
[10]   [H-3]BATRACHOTOXININ-A 20-ALPHA-BENZOATE BINDING TO SODIUM-CHANNELS IN RAT-BRAIN - SENSITIVITY TO TETRODOTOXIN AND DIVALENT-CATIONS [J].
GARRITSEN, A ;
IJZERMAN, AP ;
SOUDIJN, W .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1988, 145 (03) :261-266